πŸ‡ΊπŸ‡Έ FDA
Patent

US 9056054

Abuse resistant oral dosage forms

granted A61KA61K31/485A61K9/2027

Quick answer

US patent 9056054 (Abuse resistant oral dosage forms) held by Elite Laboratories, Inc. expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Elite Laboratories, Inc.
Grant date
Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/485, A61K9/2027, A61K9/2095, A61K9/28